Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma
Recruiting · NCT05932199 · Registry updated 2026-10-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma | Neoplasms by Histologic Type, adenoma, epithelial neoplasm, mesothelial neoplasm, mesothelioma, neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-10-02 | NCT05932199 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor College of Medicine | 267 |
| Duke Cancer Institute | 2 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor St Lukes | Houston | United States | 1 |
| Duke Cancer Institute | Durham | United States | 47 |